About: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019
Creator	Williams, L Drph, Charnetta, ; Elam-Evans, Laurie Fredua, Benjamin Markowitz, Lauri Mcnamara, Lucy Singleton, James Sterrett, Natalie Stokley, Shannon Yankey, David
source	Medline; PMC
abstract	Three vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescents aged 11-12 years to protect against 1) pertussis; 2) meningococcal disease caused by types A, C, W, and Y; and 3) human papillomavirus (HPV)-associated cancers (1). At age 16 years, a booster dose of quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended. Persons aged 16-23 years can receive serogroup B meningococcal vaccine (MenB), if determined to be appropriate through shared clinical decision-making. CDC analyzed data from the 2019 National Immunization Survey-Teen (NIS-Teen) to estimate vaccination coverage among adolescents aged 13-17 years in the United States.* Coverage with ≥1 dose of HPV vaccine increased from 68.1% in 2018 to 71.5% in 2019, and the percentage of adolescents who were up to date† with the HPV vaccination series (HPV UTD) increased from 51.1% in 2018 to 54.2% in 2019. Both HPV vaccination coverage measures improved among females and males. An increase in adolescent coverage with ≥1 dose of MenACWY (from 86.6% in 2018 to 88.9% in 2019) also was observed. Among adolescents aged 17 years, 53.7% received the booster dose of MenACWY in 2019, not statistically different from 50.8% in 2018; 21.8% received ≥1 dose of MenB, a 4.6 percentage point increase from 17.2% in 2018. Among adolescents living at or above the poverty level,§ those living outside a metropolitan statistical area (MSA)¶ had lower coverage with ≥1 dose of MenACWY and with ≥1 HPV vaccine dose, and a lower percentage were HPV UTD, compared with those living in MSA principal cities. In early 2020, the coronavirus disease 2019 (COVID-19) pandemic changed the way health care providers operate and provide routine and essential services. An examination of Vaccines for Children (VFC) provider ordering data showed that vaccine orders for HPV vaccine; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap); and MenACWY decreased in mid-March when COVID-19 was declared a national emergency (Supplementary Figure 1, https://stacks.cdc.gov/view/cdc/91795). Ensuring that routine immunization services for adolescents are maintained or reinitiated is essential to continuing progress in protecting persons and communities from vaccine-preventable diseases and outbreaks.
has issue date	2020-08-21(xsd:dateTime)
bibo:doi	10.15585/mmwr.mm6933a1
bibo:pmid	32817598
has license	cc-by
sha1sum (hex)	e801ae5fdc3808eaf65274a4e75ce0af2f9acacc
schema:url	https://doi.org/10.15585/mmwr.mm6933a1
resource representing a document's title	National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019
has PubMed Central identifier	PMC7439984
has PubMed identifier	32817598
schema:publication	MMWR Morb Mortal Wkly Rep
resource representing a document's body	covid:e801ae5fdc3808eaf65274a4e75ce0af2f9acacc#body_text
is schema:about of	named entity 'Vaccination' named entity 'Vaccination' named entity 'Adolescents' named entity 'HPV vaccination' named entity 'HPV vaccination' named entity 'VFC' named entity 'vaccination' named entity 'MSA' named entity 'HPV' named entity 'HPV vaccination' named entity 'Meningococcal conjugate vaccine' named entity 'NIS' named entity 'American Indian' named entity '5.1' named entity 'ACIP' named entity 'CDC' named entity 'meningococcal vaccines' named entity 'COVID-19 pandemic' named entity 'HPV vaccines' named entity 'MSA' named entity 'hepatitis' named entity 'acellular' named entity 'District of Columbia' named entity 'MSA' named entity 'health care providers' named entity 'CDC' named entity 'cdc' named entity 'pediatric patients' named entity 'booster dose' named entity 'cdc' named entity 'vaccination' named entity 'VFC' named entity 'Logistic regression' named entity 'meningococcal vaccine' named entity 'HPV' named entity 'vaccination' named entity 'pertussis vaccine' named entity 'human papillomavirus' named entity 'vaccination' named entity 'acellular' named entity 'HPV' named entity 'VFC' named entity 'MSA' named entity 'COVID-19 pandemic' named entity 'HPV vaccination' named entity 'HPV vaccine' named entity 'Illinois' named entity 'HPV vaccine' named entity 'Vaccines for Children' named entity 'MSA' named entity 'coverage data' named entity 'HPV vaccination' named entity 'tetanus toxoid' named entity 'NIS' named entity 'federal poverty level' named entity 'health plans' named entity 'vaccine' named entity 'COVID-19 pandemic' named entity 'VFC' named entity 'HPV' named entity 'HPV vaccine' named entity 'diphtheria toxoid' named entity 'HPV' named entity 'socioeconomic status' named entity 'HPV vaccination' named entity 'COVID-19' named entity 'metropolitan statistical area' named entity 'Chicago' named entity 'CASRO' named entity 'CASRO' named entity 'Tdap'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software